Raku Co., Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 29, 2022
Share
Raku Co., Ltd reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 133.27 million compared to TWD 97.4 million a year ago. Revenue was TWD 133.27 million compared to TWD 97.4 million a year ago. Net income was TWD 0.972 million compared to net loss of TWD 16.03 million a year ago. Basic earnings per share from continuing operations was TWD 0.03 compared to basic loss per share from continuing operations of TWD 0.54 a year ago.
For the six months, sales was TWD 231.67 million compared to TWD 207.79 million a year ago. Revenue was TWD 231.67 million compared to TWD 207.79 million a year ago. Net loss was TWD 2.95 million compared to TWD 38.93 million a year ago. Basic loss per share from continuing operations was TWD 0.08 compared to TWD 1.31 a year ago.
Raku Co Ltd, formerly Kino Biotech Co., Ltd., is a Singapore-based company. The Company is an integrated bio-nutraceutical and cosmeceutical company. The Company is focused on product conceptualization, development, commercialization, brand marketing, sale and distribution of healthcare and beauty products. The Company provides healthcare and beauty products and services through brands, including Kinohimitsu, Activa and Xpertise. It has over two logistic and distribution centers in Malaysia and China. The Company provides products to China, Singapore, Malaysia, Vietnam, Thailand and Indonesia.